Khalil Zaman

4.0k total citations
100 papers, 2.0k citations indexed

About

Khalil Zaman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khalil Zaman has authored 100 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 27 papers in Cancer Research and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khalil Zaman's work include Cancer Treatment and Pharmacology (27 papers), HER2/EGFR in Cancer Research (26 papers) and Breast Cancer Treatment Studies (22 papers). Khalil Zaman is often cited by papers focused on Cancer Treatment and Pharmacology (27 papers), HER2/EGFR in Cancer Research (26 papers) and Breast Cancer Treatment Studies (22 papers). Khalil Zaman collaborates with scholars based in Switzerland, France and United States. Khalil Zaman's co-authors include Serge Leyvraz, Laurent A. Décosterd, Maryse Fiche, Nicolas Widmer, Chantal Csajka, Bertrand Rochat, Boris Zanolari, Thierry Buclin, Michel A. Duchosal and Amina Haouala and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Khalil Zaman

87 papers receiving 1.9k citations

Peers

Khalil Zaman
Gregory D. Ayers United States
Kathrin Strasser‐Weippl Austria
E. Claire Dees United States
John Hilton Canada
Stijn L.W. Koolen Netherlands
Lissandra Dal Lago Belgium
Christian M. Kurbacher Germany
Christine M. Walko United States
Susan Ellard Canada
Lu Li China
Gregory D. Ayers United States
Khalil Zaman
Citations per year, relative to Khalil Zaman Khalil Zaman (= 1×) peers Gregory D. Ayers

Countries citing papers authored by Khalil Zaman

Since Specialization
Citations

This map shows the geographic impact of Khalil Zaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Zaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Zaman more than expected).

Fields of papers citing papers by Khalil Zaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Zaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Zaman. The network helps show where Khalil Zaman may publish in the future.

Co-authorship network of co-authors of Khalil Zaman

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Zaman. A scholar is included among the top collaborators of Khalil Zaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Zaman. Khalil Zaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Locatelli, Isabella, Khalil Zaman, Antonia Digklia, et al.. (2024). A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial. PLoS ONE. 19(6). e0304573–e0304573. 3 indexed citations
2.
Guarneri, Valentina, François P. Duhoux, Daniel Egle, et al.. (2024). Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer. Future Oncology. 20(18). 1237–1250. 1 indexed citations
3.
4.
5.
Neftel, Cyril, Khalil Zaman, Haïthem Chtioui, et al.. (2023). Elevated liver function tests in a patient with breast cancer. Journal of Hepatology. 79(3). e109–e111.
6.
Locatelli, Isabella, Perrine Courlet, Khalil Zaman, et al.. (2023). Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study. Cancers. 15(1). 316–316. 9 indexed citations
7.
Trigo, José, Khalil Zaman, María Ángeles Sala, et al.. (2023). EP13.07-06 Efficacy of Platinum Given after Lurbinectedin in Sensitive Relapsed SCLC Patients. Journal of Thoracic Oncology. 18(11). S708–S709.
8.
Courlet, Perrine, Athina Stravodimou, Haïthem Chtioui, et al.. (2022). Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics. 14(7). 1317–1317. 6 indexed citations
9.
Scabia, Valentina, Ayyakkannu Ayyanan, Fabio De Martino, et al.. (2022). Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nature Communications. 13(1). 3127–3127. 58 indexed citations
10.
Joerger, Markus, Yannis Metaxas, Khalil Zaman, et al.. (2022). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers. 14(9). 2191–2191. 3 indexed citations
11.
Zaman, Khalil, et al.. (2020). Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review. Clinical Breast Cancer. 21(3). e154–e157. 18 indexed citations
12.
Rodríguez, Elena González, Bérengère Aubry‐Rozier, Delphine Stoll, Khalil Zaman, & Olivier Lamy. (2019). Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors. Breast Cancer Research and Treatment. 179(1). 153–159. 45 indexed citations
13.
Schmid, Sabine, Dirk Klingbiel, Stefan Aebi, et al.. (2019). Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data. BMC Cancer. 19(1). 902–902. 7 indexed citations
14.
Fiche, Maryse, Valentina Scabia, Patrick Aouad, et al.. (2018). Intraductal patient‐derived xenografts of estrogen receptor α‐positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions. The Journal of Pathology. 247(3). 287–292. 27 indexed citations
15.
Cazzaniga, Marina Elena, Eva Ciruelos, Alessandra Fabi, et al.. (2018). Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project. Cancer Chemotherapy and Pharmacology. 83(2). 301–318. 2 indexed citations
16.
17.
Jacot, William, Maryse Fiche, Khalil Zaman, Anita Wolfer, & Pierre‐Jean Lamy. (2013). The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1836(1). 146–157. 45 indexed citations
18.
Brédart, Anne, Jean‐Luc Kop, Anne‐Claude Griesser, et al.. (2013). Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care. Annals of Oncology. 24(8). 2151–2158. 61 indexed citations
19.
Laurent, Julien, Cédric Touvrey, François Kuonen, et al.. (2011). Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors. Cancer Research. 71(11). 3781–3791. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory D. Ayers Breakdown of academic impact, for papers by Kathrin Strasser‐Weippl Breakdown of academic impact, for papers by E. Claire Dees Breakdown of academic impact, for papers by John Hilton Breakdown of academic impact, for papers by Stijn L.W. Koolen Breakdown of academic impact, for papers by Lissandra Dal Lago Breakdown of academic impact, for papers by Christian M. Kurbacher Breakdown of academic impact, for papers by Christine M. Walko Breakdown of academic impact, for papers by Susan Ellard Breakdown of academic impact, for papers by Lu Li
Rankless by CCL
2026